Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials.

ABSTRACT:

SUBMITTER: Simoes EAF 

PROVIDER: S-EPMC9940918 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature